148 related articles for article (PubMed ID: 1391144)
1. [Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis].
Scalon P; Di Mario F; Meggiato T; Basso D; Battaglia G; Vianello F; Fogar P; Del Favero G
Minerva Gastroenterol Dietol; 1992; 38(2):101-4. PubMed ID: 1391144
[TBL] [Abstract][Full Text] [Related]
2. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
Carvalhinhos A; Fidalgo P; Freire A; Matos L
Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
[TBL] [Abstract][Full Text] [Related]
3. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D
Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
[TBL] [Abstract][Full Text] [Related]
4. [Cisapride: clinical experience in 1071 patients with non-ulcer dyspepsia or reflux symptoms].
Fehr HF
Schweiz Med Wochenschr; 1991 Jun; 121(22):843-6. PubMed ID: 2063165
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study.
Sabbatini F; Minieri M; Manzi G; Piai G; D'Angelo V; Mazzacca G
Ital J Gastroenterol; 1991 Jan; 23(1):1-4. PubMed ID: 1747493
[TBL] [Abstract][Full Text] [Related]
6. [Morpho-functional characteristics of reflux gastritis in patients after cholecystectomy and without cholecystectomy].
Scalon P; Di Mario F; Rugge M; Meggiato T; Baffa R; Mantovani G; Plebani M; Cutolo M; Del Favero G
Minerva Gastroenterol Dietol; 1991; 37(2):113-6. PubMed ID: 1742396
[TBL] [Abstract][Full Text] [Related]
7. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
De Nutte N; Van Ganse W; Witterhulghe M; Defrance P
Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906
[TBL] [Abstract][Full Text] [Related]
8. Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment.
Santarelli L; Gabrielli M; Candelli M; Cremonini F; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):975-9. PubMed ID: 12923369
[TBL] [Abstract][Full Text] [Related]
9. Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia.
Rezende-Filho J; Di Lorenzo C; Dooley CP; Valenzuela JE
Dig Dis Sci; 1989 Jul; 34(7):1057-62. PubMed ID: 2743845
[TBL] [Abstract][Full Text] [Related]
10. [A retrospective study on the efficacy of the treatment of functional dyspepsia. An evaluation of 166 cases].
Canepa G; Di Somma C; Arnulfo G; Frascio M; Berti Riboli E
Minerva Med; 1991 Jun; 82(6):371-3. PubMed ID: 2067709
[TBL] [Abstract][Full Text] [Related]
11. Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease.
Arabehety JT; Leitão OR; Fassler S; Olarte M; Serrano C
Clin Ther; 1988; 10(4):421-8. PubMed ID: 3079010
[TBL] [Abstract][Full Text] [Related]
12. [Duodenogastric reflux in patients with functional dyspepsia].
Swiatczak C; Jawień A; Swiatkowski M; Słomiński JM; Kowiański Z
Wiad Lek; 1994 May; 47(9-10):329-32. PubMed ID: 7817588
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy of reflux oesophagitis: an update.
Tytgat GN
Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792
[TBL] [Abstract][Full Text] [Related]
14. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
McKenna CJ; Mills JG; Goodwin C; Wood JR
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia.
Gonlachanvit S; Mahachai V; Chaiwatanarat T; Kullavanijaya P
J Med Assoc Thai; 2005 May; 88(5):660-7. PubMed ID: 16149685
[TBL] [Abstract][Full Text] [Related]
16. [Incidence of Helicobacter pylori infections in patients with duodenogastric reflux].
Poniewierka E; Gościniak G; Matysiak-Budnik T
Wiad Lek; 1993 Apr; 46(7-8):271-3. PubMed ID: 8249413
[TBL] [Abstract][Full Text] [Related]
17. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
Halter F; Staub P; Hammer B; Guyot J; Miazza BM
J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and histopathological aspects in duodenogastric reflux gastritis patients with or without prior cholecystectomy.
Scalon P; Di Mario F; Del Favero G; Meggiato T; Rugge M; Baffa R; Basso D; Battistel M; Plebani M; Naccarato R
Acta Gastroenterol Belg; 1993; 56(2):215-8. PubMed ID: 8368047
[TBL] [Abstract][Full Text] [Related]
19. Effects of sucralfate and sulglycotide treatment on active gastritis and Helicobacter pylori colonization of the gastric mucosa in non-ulcer dyspepsia patients.
Barbara L; Biasco G; Capurso L; Dobrilla G; Lalli A; Paganelli GM; Pallone F; Torsoli A
Am J Gastroenterol; 1990 Sep; 85(9):1109-13. PubMed ID: 2202200
[TBL] [Abstract][Full Text] [Related]
20. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
